Daily economic reports

The latest sentiment in AI markets signals a 10% perceived risk of a bubble burst before New Year’s Day, yet some analysts, including Citadel’s Ken Griffin, still view the sector as a long‑term hold. Even in uncertainty, AI‑powered productivity improvements keep the fundamentals sound, but volatility may dampen short‑term capital flows into high‑valuation chip and platform firms. China’s macro data shows growth exceeding forecasts, largely thanks to a surge in exports, with AI playing a noticeable role in boosting manufacturing efficiency. This, coupled with the World Bank’s observation that ‘small AI’ can transform emerging economies, suggests a potential dual track: developed markets channel research and capital while developing regions adopt AI for productivity leaps. In the UK, a quick turnaround in fiscal metrics—deficit rising to £24.5bn, inflation climbing to 3.5%, yet unemployment falling to 4.7%—creates a delicate balancing act for Treasurer Neil Healey. The IMF’s stance that spending cuts outweigh bank‑taxation, combined with a looming budget, points to potential tightening that could cool inflation but potentially dampen growth. On the biotech front, Moderna’s forthcoming cancer‑vaccine trial results will be a barometer of medical‑innovation momentum. A positive outcome could raise expectations for therapeutic biotech investments, while a neutral or negative result may dampen enthusiasm for pharma R&D spend. Euro‑region weather reports indicate that extreme heatwaves are not deterring holiday travel plans, signaling a resilience in leisure demand. However, continued climatic stresses may prompt higher operating costs for hospitality and airlines, subtly affecting revenue streams and employment patterns.